Hossein Amini, PhD, is a senior lecturer at the Data Analytics Group in Olin Business School. Amini focuses on health care analytics and AI, particularly using data from the FDA Adverse Event Reporting System to assess drug safety. He develops machine-learning and topic-modeling methods to study disease severity, treatment toxicity, and COVID-era shifts, and builds applied AI tools for research, teaching, and business decision-making.